Table 3.
Plasma fatty acids concentration.
| Fatty Acids (mol/L) | Groups | |||
|---|---|---|---|---|
| Sham | ShamC | 5/6Nx | 5/6NxC | |
| Lauric acid (C12) | 0.005 ± 0.009 | 0.006 ± 0.002 | 0.004 ± 0.001 | 0.003 ± 0.001 & |
| Miristic acid (C14) | 0.004 ± 0.002 | 0.004 ± 0.002 | 0.006 ± 0.003 | 0.004 ± 0.001 |
| Palmitic acid (C16) | 0.119 ± 0.039 | 0.113 ± 0.011 | 0.193 ± 0.046 & | 0.169 ± 0.023 $& |
| Palmitoleic acid (C16:1n-7) | 0.002 ± 0.001 | 0.004 ± 0.002 | 0.012 ± 0.002 $& | 0.006 ± 0.002 $# |
| Estearic acid (C18) | 0.057 ± 0.014 | 0.052 ± 0.006 | 0.093 ± 0.019 $& | 0.088 ± 0.018 $& |
| Oleic acid (C18:1n-9) | 0.054 ± 0.028 | 0.050 ± 0.010 | 0.091 ± 0.036 & | 0.076 ± 0.019 |
| Linoleic acid (C18:2n-6) | 0.083 ± 0.034 | 0.079 ± 0.015 | 0.160 ± 0.037 $& | 0.125 ± 0.022 & |
| α-Linolenic acid (C18:3n-3) | 0.002 ± 0.001 | 0.002 ± 0.001 | 0.004 ± 0.002 | 0.002 ± 0.001 |
| γ-Linolenic acid (C18:3n-6) | 0.001 ± 0.0004 | 0.002 ± 0.0003 | 0.002 ± 0.001 | 0.002 ± 0.0003 |
| Dihomo-gamma-linolenic acid (C20:3n-6) | 0.001 ± 0.0007 | 0.002 ± 0.0009 | 0.002 ± 0.0009 | 0.002 ± 0.0002 |
| Arachidonic acid (C20) | 0.068 ± 0.012 | 0.049 ± 0.008 | 0.133 ± 0.029 $& | 0.099 ± 0.029 & |
| Saturated fatty acids | 0.210 ± 0.058 | 0.180 ± 0.022 | 0.299 ± 0.068 $& | 0.255 ± 0.039 & |
| Unsaturated fatty acids | 0.063 ± 0.029 | 0.051 ± 0.013 | 0.115 ± 0.031 $& | 0.075 ± 0.011 # |
| Polyunsaturated fatty acids | 0.093 ± 0.038 | 0.087 ± 0.013 | 0.169 ± 0.040 $& | 0.129 ± 0.023 |
| Total | 0.419 ± 0.151 | 0.378 ± 0.056 | 0.680 ± 0.182 $& | 0.552 ± 0.082 |
ANOVA, post hoc Tukey, Mean ± SD, p < 0.05, n = 6–8. $ p < 0.05 v.s Sham, & p < 0.05 vs. ShamC, # p < 0.05 vs. 5/6Nx. ShamC = Sham + curcumin, 5/6Nx: five-sixths nephrectomy 5/6NxC = 5/6Nx + curcumin.